Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1984 May;82(1):295–301. doi: 10.1111/j.1476-5381.1984.tb16471.x

Regional differences in the response to vasoconstrictor agents of dog and monkey isolated coronary arteries.

K Miwa, N Toda
PMCID: PMC1987246  PMID: 6587928

Abstract

Contractile responses to vasoconstrictor agents were compared in helical strips of dog and monkey epicardial coronary arteries of different sizes. Contractions of large, medium and small arteries induced by KCl ( 30mM ) were virtually identical. Contractions induced by 5-hydroxytryptamine (5-HT) (10(-9) - 2 X 10(-6) M) were in the order of large greater than medium greater than small arteries in dogs, and large = medium greater than small arteries in monkeys. Cinanserin suppressed these responses. In contrast, contractions produced by angiotensin II (AII) (10(-7) M) were in the order of small greater than medium greater than large arteries in dogs, and small greater than medium = large arteries in monkeys. Sar1-Ala8-angiotensin II markedly attenuated the peptide-induced contractions. Contractions induced by prostaglandin F2 alpha (PGF2 alpha) were significantly greater in large and medium sized arteries than in small arteries in dogs, while those of the arteries of different sizes isolated from monkeys did not differ. Contractions induced by carbocyclic thromboxane A2 (c-TXA2), in arteries of different sizes in dogs and monkeys, did not differ. These results suggest that the sensitivity and/or the population of 5-HT receptors are greater in proximal coronary arteries than in distal arteries, while, in contrast, the sensitivity and/or population of AII receptors are greater in distal coronary arteries. Receptors for PGF2 alpha and c-TXA2 appear to react to a similar degree in monkey arteries of different sizes, although receptors for PGF2 alpha appear to be fewer in distal coronary arteries in dogs.

Full text

PDF
295

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brazenor R. M., Angus J. A. Ergometrine contracts isolated canine coronary arteries by a serotonergic mechanism: no role for alpha adrenoceptors. J Pharmacol Exp Ther. 1981 Aug;218(2):530–536. [PubMed] [Google Scholar]
  2. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373–376. doi: 10.1038/288373a0. [DOI] [PubMed] [Google Scholar]
  3. HADDY F. J., FLEISHMAN M., EMANUEL D. A. Effect of epinephrine, norepinephrine and serotonin upon systemic small and large vessel resistance. Circ Res. 1957 May;5(3):247–251. doi: 10.1161/01.res.5.3.247. [DOI] [PubMed] [Google Scholar]
  4. HADDY F. J., MOLNAR J. I., BORDEN C. W., TEXTER E. C., Jr Comparison of direct effects of angiotensin and other vasoactive agents on small and large blood vessels in several vascular beds. Circulation. 1962 Jan;25:239–246. doi: 10.1161/01.cir.25.1.239. [DOI] [PubMed] [Google Scholar]
  5. Hayashi S., Toda N. Responses of isolated dog coronary arteries to tyramine. Jpn J Pharmacol. 1982 Feb;32(1):47–54. doi: 10.1254/jjp.32.47. [DOI] [PubMed] [Google Scholar]
  6. Heupler F. A., Jr, Proudfit W. L., Razavi M., Shirey E. K., Greenstreet R., Sheldon W. C. Ergonovine maleate provocative test for coronary arterial spasm. Am J Cardiol. 1978 Apr;41(4):631–640. doi: 10.1016/0002-9149(78)90810-x. [DOI] [PubMed] [Google Scholar]
  7. Lefer A. M., Smith E. F., 3rd, Araki H., Smith J. B., Aharony D., Claremon D. A., Magolda R. L., Nicolaou K. C. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1706–1710. doi: 10.1073/pnas.77.3.1706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Müller-Schweinitzer E. The mechanism of ergometrine-induced coronary arterial spasm: in vitro studies on canine arteries. J Cardiovasc Pharmacol. 1980 Sep-Oct;2(5):645–655. doi: 10.1097/00005344-198009000-00013. [DOI] [PubMed] [Google Scholar]
  9. Oliva P. B., Breckinridge J. C. Arteriographic evidence of coronary arterial spasm in acute myocardial infarction. Circulation. 1977 Sep;56(3):366–374. doi: 10.1161/01.cir.56.3.366. [DOI] [PubMed] [Google Scholar]
  10. Oliva P. B., Potts D. E., Pluss R. G. Coronary arterial spasm in Prinzmetal angina. Documentation by coronary arteriography. N Engl J Med. 1973 Apr 12;288(15):745–751. doi: 10.1056/NEJM197304122881501. [DOI] [PubMed] [Google Scholar]
  11. Porquet M. F., Pourrias B., Santamaria R. Effects of 5-hydroxytryptamine on canine isolated coronary arteries. Br J Pharmacol. 1982 Feb;75(2):305–310. doi: 10.1111/j.1476-5381.1982.tb08787.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Smith E. F., 3rd, Lefer A. M., Nicolaou K. C. Mechanism of coronary vasoconstriction induced by carbocyclic thromboxane A2. Am J Physiol. 1981 Apr;240(4):H493–H497. doi: 10.1152/ajpheart.1981.240.4.H493. [DOI] [PubMed] [Google Scholar]
  13. Tada M., Kuzuya T., Inoue M., Kodama K., Mishima M., Yamada M., Inui M., Abe H. Elevation of thromboxane B2 levels in patients with classic and variant angina Pectoris. Circulation. 1981 Dec;64(6):1107–1115. doi: 10.1161/01.cir.64.6.1107. [DOI] [PubMed] [Google Scholar]
  14. Toda N., Hatano Y., Hayashi S. Modifications by stretches of the mechanical response of isolated cerebral and extracerebral arteries to vasoactive agents. Pflugers Arch. 1978 Apr 25;374(1):73–77. doi: 10.1007/BF00585699. [DOI] [PubMed] [Google Scholar]
  15. Toda N., Miyazaki M. Regional and species differences in the response of isolated arteries to angiotnesin II. Jpn J Pharmacol. 1978 Jun;28(3):495–497. doi: 10.1254/jjp.28.495. [DOI] [PubMed] [Google Scholar]
  16. Toda N. Response of isolated monkey coronary arteries to catecholamines and to transmural electrical stimulation. Circ Res. 1981 Dec;49(6):1228–1236. doi: 10.1161/01.res.49.6.1228. [DOI] [PubMed] [Google Scholar]
  17. Yasue H., Omote S., Takizawa A., Nagao M., Miwa K., Tanaka S. Exertional angina pectoris caused by coronary arterial spasm: effects of various drugs. Am J Cardiol. 1979 Mar;43(3):647–652. doi: 10.1016/0002-9149(79)90026-2. [DOI] [PubMed] [Google Scholar]
  18. Yasue H. Pathophysiology and treatment of coronary arterial spasm. Chest. 1980 Jul;78(1 Suppl):216–223. doi: 10.1378/chest.78.1_supplement.216. [DOI] [PubMed] [Google Scholar]
  19. ZUBERBUHLER R. C., BOHR D. F. RESPONSES OF CORONARY SMOOTH MUSCLE TO CATECHOLAMINES. Circ Res. 1965 May;16:431–440. doi: 10.1161/01.res.16.5.431. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES